Sentences with phrase «future cancer studies»
Your gift will support cancer research in dogs, cats, horses and wildlife, increasing funding for current and future cancer studies.
https://www.morrisanimalfoundation.org/ Not exact matches
Babies can get sunburned after just a few minutes in the sun and studies have shown that sun exposure during childhood is related to future risk of skin cancer, so it's important to protect your baby when playing outside.
And recently, the group has begun a clinical study to predict, after one treatment, how an individual's cancer will progress, and use that prediction to plan the future course of treatment.
It will drive the study of cancer immunotherapy in the future.»
Dr. Rositch adds, «It will be important to clarify in future studies whether the continued increase in cervical cancer rates with age and the higher rates in African - American women represent a failure in our screening programs or a failure of the women to be screened so that appropriate interventions can be applied.»
«Future studies will not only seek to further map the function of AIM2 in infectious diseases, but also to track its role in other disorders, including cancer,» Man said.
In future studies, the researchers will study how the HPV16 genome changes over time within individuals to better understand how cancer develops.
Study authors intend to perform additional research in the future to follow up on their estimate of how well the current vaccines protect against HPV - associated cancers.
«This study's results can have practice changing implications on how future prostate cancer trials are designed in terms of identifying the men for these studies who are at high risk for early death due to ineffective initial treatment for their prostate cancer,» stated Anthony Victor D'Amico, MD, PhD, chief, Genitourinary Radiation Oncology, Brigham and Women's Hospital and senior author of the study.
«Future comparative oncology studies, optimizing the delivery of PMed strategies, may aid cancer drug development.»
«This study forms the basis for future research in patients with breast cancer and offers hope for targeted therapy for patients with aggressive triple - negative inflammatory breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.
They also set reference points for future studies looking at the connection between metabolic processes and diseases such as cancer.»
Future studies are planned by Chang and other School of Medicine researchers — including senior author Kenneth R. Carson, MD, PhD, an assistant professor of oncology, and Graham Colditz, MD, DrPH, a cancer expert who also is associate director of prevention and control at Siteman Cancer Center at Washington University School of Medicine and Barnes - Jewish Hoscancer expert who also is associate director of prevention and control at Siteman Cancer Center at Washington University School of Medicine and Barnes - Jewish HosCancer Center at Washington University School of Medicine and Barnes - Jewish Hospital.
The studies not only point to the future possibility of specific microRNAs as a treatment for colorectal cancer, but also to the importance of external metabolic events conducted outside the cancer cell in the progression of the disease — factors that could someday be targeted to help slow metastasis, or even block it entirely.
Dr. Xu and his team currently are planning follow - up studies, hopeful that these could lead to a life - extending therapy for pancreatic cancer patients in the not - too - distant future.
The findings of this study may be useful for planning future support programs for cancer patients, and can provide additional information to guide programs for people with specific cancer types.
A study of over 224,000 patients and more than 314,000 colonoscopies found that adenoma detection rates closely tracked the future risk of colorectal cancer.
Dr. David Fredricks, a physician - scientist at Fred Hutchinson Cancer Research Center and senior author of the study, said the results could lead to a better understanding of how biological conditions may promote infection by the virus that causes AIDS, and perhaps offer targets for future prevention research.
«By understanding how stress accelerates invasion in aggressive breast tumor cells, this work will inform future studies into whether beta - blockers could be a useful adjuvant therapy in the treatment of some aggressive breast cancers.»
Parker, meanwhile, is optimistic that future studies of the genetics of cancer may yield some insights.
The study did not address when or how to remove lymph node tissue surgically, as is often done as part of breast cancer treatment, but Popel and colleagues hope to explore the issue in future studies.
White and colleagues will work with other collaborators at the Cancer Institute to develop early - phase patient clinical trials based on the findings from this study in the near future.
Future study of vlincRNAs may illuminate the biological principles that link together stem cells and cancer.
But the implications of a recent study demonstrating this relationship are anything but simple and could influence both the design of future clinical trials and the goals of oncologists treating cancer.
Dr. Oesterreich and her colleagues propose that future studies look at offering a combined therapy that, along with aromatase inhibitors, also introduces drugs that modify the epigenome to prevent or delay the cancer from repressing cancer - killing genes.
Shalowitz and colleagues suggest future studies should focus on defining areas with poor clinical outcomes attributed to geographic factors, and creating a comprehensive national, geographically - linked database on the utilization of gynecologic cancer care and clinical outcomes.
Additionally, since ribosomal RNA has been shown to have specified controlled of cellular fate, this study provides a theoretical basis for disease therapy and neuroscience research and may lead to future advances in treating degenerative diseases or even brain cancers.
The authors believe theirs is the first study to show that mouse mammary gland tissues are sensitive to a mixture of 23 commonly used UOG chemicals, with dose - specific effects on tissue morphology, cell proliferation and induction of intraductal hyperplasias, an overgrowth of cells considered a marker for future breast cancer risk.
The effect of these findings on the long - term health of the mammary gland, including its lactational capacity and its risk of cancer, should be evaluated in future studies.»
However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health - related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.
«In the future we hope to apply this strategy to target other disease - causing RNAs, which range from incurable cancers to important viral pathogens such as Zika and Ebola,» added Research Associate Sai Pradeep Velagapudi, the first author of the study and a member of the Disney lab.
«The majority of cancer patients we work with are excited to participate in clinical trials that could benefit future patient outcomes down the line,» says co-senior author Bryan Allen, who led the clinical side of the study.
«Studies like this also give us a better understanding of how cancer changes to evade treatments — knowledge we can use when we are designing the new cancer drugs of the future.»
«In addition, although many shared properties exist between infection and cancer, future studies identifying distinct regulatory wiring in cancer - infiltrating T cells are essential for the continued progress of cancer immunotherapy.»
«If [the result] holds up in future studies, it suggests that there is a genetic component — and that a single gene contributes a great deal,» says Leonid Kruglyak, a geneticist at the Fred Hutchinson Cancer Research Center in Seattle.
«Our findings reveal that a high degree of future orientation appears to be protective against eating frequently at fast food establishments,» said Kerem Shuval, PhD, of the American Cancer Society, lead author of the study.
A study projects 130 future cancer deaths from the meltdowns at the reactors in Fukushima last year, but does that suggest nuclear power is safer than fossil fuel alternatives?
«This study will inform development of technology for a future test that could eventually be used as a blood test for early cancer detection.
Alexis Borisy, CEO of Foundation Medicine, a cancer diagnostics company in Cambridge, Massachusetts, that studies how genetics can be translated into therapies, says that the study is «an excellent example of a coming wave of information from cancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other procancer diagnostics company in Cambridge, Massachusetts, that studies how genetics can be translated into therapies, says that the study is «an excellent example of a coming wave of information from cancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other procancer genomes» that he expects to be sequenced in the future through the Cancer Genome Atlas and other proCancer Genome Atlas and other projects.
«We urgently need markers to predict which therapies are going to be effective and which will not be effective in individual patients with advanced prostate cancer,» said lead study author Emmanuel Antonarakis, MD, an assistant professor of oncology and urology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Md. «AR - V7 testing may be extremely valuable in guiding treatment decisions for men with hormone - resistant disease in the near future.&cancer,» said lead study author Emmanuel Antonarakis, MD, an assistant professor of oncology and urology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Md. «AR - V7 testing may be extremely valuable in guiding treatment decisions for men with hormone - resistant disease in the near future.&Cancer Center at Johns Hopkins in Baltimore, Md. «AR - V7 testing may be extremely valuable in guiding treatment decisions for men with hormone - resistant disease in the near future.»
In the future, we will be able to conduct such studies in men who have prostate cancer and gain important information about this plant component's anti-cancer activity,» said John W. Erdman Jr., a U of I emeritus professor of nutrition.
Dr. Kirino says that «further studies to understand how SHOT - RNAs promote cell proliferation may lead to the use of SHOT - RNAs as potential target candidates for future therapeutic applications in breast and prostate cancers.»
Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology and related disciplines.
Now, a collaborative study, with a Huddersfield professor, has enabled future doctors to experience some of the challenges patients living with skin cancer can face to develop a greater empathy for their patients.
In future studies, the researchers will continue to explore the mechanisms by which SRCs kill cancer cells and will screen for even better SRC activators.
A Houston Methodist team led by Mauro Ferrari, PhD and Jenny Chang, MD has received funding from the U.S. Department of Defense to complete preclinical efficacy studies and a future clinical trial testing a breast cancer precision drug.
Ultimately, this will provide for current and future studies such as those that evaluate the correlation of biological markers with clinical variables and cancer outcomes, as well as those that identify interactions among biological markers.
The study, «Alcohol Challenge Responses Predict Future Alcohol Use Disorder Symptoms: A 6 - Year Prospective Study,» was supported by the National Institute on Alcohol Abuse and Alcoholism, the Alcoholic Beverage Medical Research Foundation, the University of Chicago Comprehensive Cancer Center, the National Center for Research Resources, the National Institutes of Health Roadmap for Medical Research and the New York State Psychiatric Instistudy, «Alcohol Challenge Responses Predict Future Alcohol Use Disorder Symptoms: A 6 - Year Prospective Study,» was supported by the National Institute on Alcohol Abuse and Alcoholism, the Alcoholic Beverage Medical Research Foundation, the University of Chicago Comprehensive Cancer Center, the National Center for Research Resources, the National Institutes of Health Roadmap for Medical Research and the New York State Psychiatric InstiStudy,» was supported by the National Institute on Alcohol Abuse and Alcoholism, the Alcoholic Beverage Medical Research Foundation, the University of Chicago Comprehensive Cancer Center, the National Center for Research Resources, the National Institutes of Health Roadmap for Medical Research and the New York State Psychiatric Institute.
Together, this translational program is developed within the National Cancer and Cognition Platform (CNO / Ligue Nationale contre le cancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population atCancer and Cognition Platform (CNO / Ligue Nationale contre le cancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population atcancer), with the aim to collaborate in a structured way with French oncology groups, research teams as well as pharmaceutical industry, by providing preclinical models and guidance on standard operating procedures for ancillary or future studies in identified population at risk.
If future, large - scale studies replicate these findings then genetic testing based on these results can serve as a tool for assessing an individual's risk for developing certain types of cancer, Dr. Eng said.